INTER-TUMOR HETEROGENEITY OF PD-L1 EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER AND ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA AMONG PATIENTS IN ALEXANDRIA, EGYPT

INTER-TUMOR HETEROGENEITY OF PD-L1 EXPRESSION IN ADVANCED ‎NON-SMALL CELL LUNG CANCER AND ADVANCED HEAD AND NECK ‎SQUAMOUS CELL CARCINOMA AMONG PATIENTS IN ALEXANDRIA, ‎EGYPT .

Expression of programmed death ligand 1 (PD-L1) in urothelial bladder carcinoma (immunohistochemical and histopathological study)

Pathological Pattern of Urinary Bladder Cancer: Data from a Single Egyptian Institute

Prognostic Value of Tumour Infiltrating T-Lymphocytes (Tils) with Special Preference to CD8 Positive T-Lymphocyte in Muscle Invasive Urothelial Bladder Cancer

Evaluation of Neoadjuvant Chemotherapy in Treatment of Muscle Invasive Urothelial Bladder Tumors in Upper Egypt

Epidemiological and Clinico-Pathological Characteristics of Bladder Cancer at Clinical Oncology Department, Zagazig University: Retrospective Analysis

Review Article: Prognostic Value of CK5/6 Expression in Urinary Bladder Carcinoma

EXPRESSION OF CYTOKERATIN 7, 20, 14 IN UROTHELIAL CARCINOMA AND SQUAMOUS CELL CARCINOMA OF THE EGYPRIAN URINARY BLADDER CANCER

Clinico-pathological Features of Squamous Cell Carcinoma of Urinary Bladder at South Egypt Cancer Institute (Retrospective Study)